Literature DB >> 6237130

Porokeratosis of Mibelli: benzylhydrochlorothiazide-induced new lesions accompanied by eosinophilic spongiosis.

N Inamoto, T Watanabe, K Nakamura.   

Abstract

We observed the course of development of porokeratosis stimulated by benzylhydrochlorothiazide (BHCTh) in normal-appearing skin of a patient with long-standing stable porokeratosis of Mibelli. A 72-year-old Japanese man had had porokeratosis of Mibelli for more than 50 years. During administration of BHCTh for 1 year because of his hypertension, a lichenoid drug eruption developed over the lesions of porokeratosis on the flexor aspects of his legs. Readministration of BHCTh by another physician for 6 months resulted in the occurrence of a similar drug eruption that converted into typical skin lesions of porokeratosis 8 weeks later. Serial microscopic examination suggested that BHCTh administration resulted in eosinophilic spongiosis and cornoid lamella formation, which developed into epidermal changes characteristic of porokeratosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237130     DOI: 10.1016/s0190-9622(84)70172-1

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  [Inflammatory stage of disseminated superficial porokeratosis in a 71-year old patient].

Authors:  N Klein; A Enk; W Hartschuh
Journal:  Hautarzt       Date:  2009-05       Impact factor: 0.751

2.  Genital porokeratosis of Mibelli.

Authors:  I Neri; S Marzaduri; B Passarini; A Patrizi
Journal:  Genitourin Med       Date:  1995-12

3.  Porokeratosis of Mibelli in an immunosuppressed patient.

Authors:  F M Tatnall; I Sarkany
Journal:  J R Soc Med       Date:  1987-03       Impact factor: 18.000

4.  Disseminated Porokeratosis with Idiopathic Thrombocytopenia - Case Report and Literature Review of Porokeratosis and Related Disorders.

Authors:  Anastasiya Atanasova Chokoeva; Uwe Wollina; Torello Lotti; Georgi Konstantinov Maximov; Ilia Lozev; Georgi Tchernev
Journal:  Open Access Maced J Med Sci       Date:  2018-01-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.